Return to homepagePandemic Pact

to evaluate the efficacy of concentrated convalescent plasma enriched for anti-S IgG in high-risk elderly people post-exposure to SARS-CoV2

Grant number: INV-017995

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2020

  • Known Financial Commitments (USD)

    $534,332

  • Funder

    Gates Foundation

  • Principal Investigator

    .

  • Research Location

    Argentina

  • Lead Research Institution

    Fundación INFANT

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Older adults (65 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Publicationslinked via Europe PMC

Last Updated:7 days ago

View all publications at Europe PMC

Post-trial follow-up after a randomized clinical trial of COVID-19 convalescent plasma